{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:37:40Z","timestamp":1790789860195,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T00:00:00Z","timestamp":1643155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>T-cell acute lymphoblastic leukemias (T-ALL) represent 15% of pediatric and 25% of adult ALL. Since they have a particularly poor outcome in relapsed\/refractory cases, identifying prognosis factors at diagnosis is crucial to adapting treatment for high-risk patients. Unlike acute myeloid leukemia and BCP ALL, chromosomal rearrangements leading to chimeric fusion-proteins with strong prognosis impact are sparsely reported in T-ALL. To address this issue an RT-MPLA assay was applied to a consecutive series of 522 adult and pediatric T-ALLs and identified a fusion transcript in 20% of cases.<jats:italic>PICALM-MLLT10<\/jats:italic>(4%,<jats:italic>n<\/jats:italic>\u2009=\u200923),<jats:italic>NUP214-ABL1<\/jats:italic>(3%,<jats:italic>n<\/jats:italic>\u2009=\u200919) and<jats:italic>SET-NUP214<\/jats:italic>(3%,<jats:italic>n<\/jats:italic>\u2009=\u200918) were the most frequent. The clinico-biological characteristics linked to fusion transcripts in a subset of 235 patients (138 adults in the GRAALL2003\/05 trials and 97 children from the FRALLE2000 trial) were analyzed to identify their prognosis impact. Patients with HOXA trans-deregulated T-ALLs with MLLT10, KMT2A and SET fusion transcripts (17%, 39\/235) had a worse prognosis with a 5-year EFS of 35.7% vs 63.7% (HR\u2009=\u20091.63;<jats:italic>p<\/jats:italic>\u2009=\u20090.04) and a trend for a higher cumulative incidence of relapse (5-year CIR\u2009=\u200945.7% vs 25.2%, HR\u2009=\u20091.6;<jats:italic>p<\/jats:italic>\u2009=\u20090.11). Fusion transcripts status in T-ALL can be robustly identified by RT-MLPA, facilitating risk adapted treatment strategies for high-risk patients.<\/jats:p>","DOI":"10.1038\/s41408-022-00613-9","type":"journal-article","created":{"date-parts":[[2022,1,26]],"date-time":"2022-01-26T08:02:54Z","timestamp":1643184174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins"],"prefix":"10.1038","volume":"12","author":[{"given":"Thomas","family":"Steiml\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Emilie","family":"Dourthe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2912-0343","authenticated-orcid":false,"given":"Marion","family":"Alcantara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Touzart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Simonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Mondesir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2498-0376","authenticated-orcid":false,"given":"Ludovic","family":"Lhermitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Bond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Graux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Grardel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Cayuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Arnoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Gandemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Balsat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7027-040X","authenticated-orcid":false,"given":"Norbert","family":"Vey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0520-0493","authenticated-orcid":false,"given":"Elizabeth","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Ifrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Dombret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8363-1622","authenticated-orcid":false,"given":"Arnaud","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Baruchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Ruminy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Boissel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6255-5314","authenticated-orcid":false,"given":"Vahid","family":"Asnafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,26]]},"reference":[{"key":"613_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","volume":"1","author":"AA Ferrando","year":"2002","unstructured":"Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 2002;1:75\u201387.","journal-title":"Cancer Cell"},{"key":"613_CR2","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1182\/blood-2002-09-2913","volume":"102","author":"V Asnafi","year":"2003","unstructured":"Asnafi V, Radford-Weiss I, Dastugue N, Bayle C, Leboeuf D, Charrin C, et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. Blood. 2003;102:1000\u20136.","journal-title":"Blood"},{"key":"613_CR3","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","volume":"33","author":"C-H Pui","year":"2015","unstructured":"Pui C-H, Yang JJ, Hunger SP, Pieters R, Schrappe M, Biondi A, et al. Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration. J Clin Oncol. 2015;33:2938\u201348.","journal-title":"J Clin Oncol"},{"key":"613_CR4","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","volume":"371","author":"C-H Pui","year":"2008","unstructured":"Pui C-H, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371:1030\u201343.","journal-title":"Lancet"},{"key":"613_CR5","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.3109\/10428194.2014.894191","volume":"55","author":"J Hocking","year":"2014","unstructured":"Hocking J, Schwarer AP, Gasiorowski R, Patil S, Avery S, Gibson J, et al. Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocol. Leuk Lymphoma. 2014;55:2801\u20137.","journal-title":"Leuk Lymphoma"},{"key":"613_CR6","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1200\/JCO.2008.18.6916","volume":"27","author":"F Huguet","year":"2009","unstructured":"Huguet F, Leguay T, Raffoux E, Thomas X, Beldjord K, Delabesse E, et al. Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome\u2013Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study. JCO. 2009;27:911\u20138.","journal-title":"JCO"},{"key":"613_CR7","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/sj.leu.2404302","volume":"20","author":"C Graux","year":"2006","unstructured":"Graux C, Cools J, Michaux L, Vandenberghe P, Hagemeijer A. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast. Leukemia. 2006;20:1496\u2013510.","journal-title":"Leukemia"},{"key":"613_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1365-2141.2008.07314.x","volume":"143","author":"P Van Vlierberghe","year":"2008","unstructured":"Van Vlierberghe P, Pieters R, Beverloo HB, Meijerink JP. Molecular-genetic insights in paediatric T-cell acute lymphoblastic leukaemia. Br J Haematol. 2008;143:153\u201368.","journal-title":"Br J Haematol"},{"key":"613_CR9","doi-asserted-by":"publisher","unstructured":"Fattizzo B, Rosa J, Giannotta JA, Baldini L, Fracchiolla NS. The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: focus on Molecular Aspects. Front Oncol. 2020;10. https:\/\/doi.org\/10.3389\/fonc.2020.00273.","DOI":"10.3389\/fonc.2020.00273"},{"key":"613_CR10","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/ng.3909","volume":"49","author":"Y Liu","year":"2017","unstructured":"Liu Y, Easton J, Shao Y, Maciaszek J, Wang Z, Wilkinson MR, et al. The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. Nat Genet. 2017;49:1211\u20138.","journal-title":"Nat Genet"},{"key":"613_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012;481:157\u201363.","journal-title":"Nature"},{"key":"613_CR12","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nrc.2016.63","volume":"16","author":"L Belver","year":"2016","unstructured":"Belver L, Ferrando A. The genetics and mechanisms of T cell acute lymphoblastic leukaemia. Nat Rev Cancer. 2016;16:494\u2013507.","journal-title":"Nat Rev Cancer"},{"key":"613_CR13","doi-asserted-by":"crossref","unstructured":"Yang JJ, Park TS, Wan TSK. Recurrent Cytogenetic Abnormalities in Acute Myeloid Leukemia. In: Wan TSK, editors. Cancer Cytogenetics: Methods and Protocols. New York, NY:Springer; 2017. p. 223\u201345.","DOI":"10.1007\/978-1-4939-6703-2_19"},{"key":"613_CR14","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1097\/HS9.0000000000000053","volume":"2","author":"C Schwab","year":"2018","unstructured":"Schwab C, Harrison CJ. Advances in B-cell Precursor Acute Lymphoblastic Leukemia Genomics. Hemasphere. 2018;2:e53.","journal-title":"Hemasphere"},{"key":"613_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1073\/pnas.1717125115","volume":"115","author":"B Chen","year":"2018","unstructured":"Chen B, Jiang L, Zhong M-L, Li J-F, Li B-S, Peng L-J, et al. Identification of fusion genes and characterization of transcriptome features in T-cell acute lymphoblastic leukemia. PNAS. 2018;115:373\u20138.","journal-title":"PNAS"},{"key":"613_CR16","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1038\/leu.2016.60","volume":"30","author":"K Matlawska-Wasowska","year":"2016","unstructured":"Matlawska-Wasowska K, Kang H, Devidas M, Wen J, Harvey RC, Nickl CK, et al. MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children\u2019s Oncology Group Study. Leukemia. 2016;30:1909\u201312.","journal-title":"Leukemia"},{"key":"613_CR17","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.3900","volume":"49","author":"M Seki","year":"2017","unstructured":"Seki M, Kimura S, Isobe T, Yoshida K, Ueno H, Nakajima-Takagi Y, et al. Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia. Nat Genet. 2017;49:1274\u201381.","journal-title":"Nat Genet"},{"key":"613_CR18","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.1182\/blood-2007-09-111872","volume":"111","author":"P Van Vlierberghe","year":"2008","unstructured":"Van Vlierberghe P, van Grotel M, Tchinda J, Lee C, Beverloo HB, van der Spek PJ, et al. The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. Blood. 2008;111:4668\u201380.","journal-title":"Blood"},{"key":"613_CR19","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1182\/blood-2013-02-487256","volume":"121","author":"L Brandimarte","year":"2013","unstructured":"Brandimarte L, Pierini V, Di Giacomo D, Borga C, Nozza F, Gorello P, et al. New MLLT10 gene recombinations in pediatric T-acute lymphoblastic leukemia. Blood. 2013;121:5064\u20137.","journal-title":"Blood"},{"key":"613_CR20","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1182\/blood-2013-08-521518","volume":"123","author":"R Ben Abdelali","year":"2014","unstructured":"Ben Abdelali R, Roggy A, Leguay T, Cieslak A, Renneville A, Touzart A, et al. SET-NUP214 is a recurrent \u03b3\u03b4 lineage-specific fusion transcript associated with corticosteroid\/chemotherapy resistance in adult T-ALL. Blood. 2014;123:1860\u20133.","journal-title":"Blood"},{"key":"613_CR21","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1182\/blood-2002-08-2438","volume":"101","author":"V Asnafi","year":"2003","unstructured":"Asnafi V, Beldjord K, Boulanger E, Comba B, Le Tutour P, Estienne MH, et al. Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment. Blood. 2003;101:2693\u2013703.","journal-title":"Blood"},{"key":"613_CR22","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1046\/j.1365-2141.1997.4833286.x","volume":"99","author":"E Delabesse","year":"1997","unstructured":"Delabesse E, Bernard M, Landman-Parker J, Davi F, Leboeuf D, Varet B, et al. Simultaneous SIL-TAL1 RT-PCR detection of all tal(d) deletions and identification of novel tal(d) variants. Br J Haematol. 1997;99:901\u20137.","journal-title":"Br J Haematol"},{"key":"613_CR23","doi-asserted-by":"publisher","first-page":"4173","DOI":"10.1182\/blood-2003-11-3944","volume":"104","author":"V Asnafi","year":"2004","unstructured":"Asnafi V, Beldjord K, Libura M, Villarese P, Millien C, Ballerini P, et al. Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy. Blood. 2004;104:4173\u201380.","journal-title":"Blood"},{"key":"613_CR24","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1182\/blood-2001-11-0093","volume":"100","author":"P Ballerini","year":"2002","unstructured":"Ballerini P, Blaise A, Busson-Le Coniat M, Su XY, Zucman-Rossi J, Adam M, et al. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. Blood. 2002;100:991\u20137.","journal-title":"Blood"},{"key":"613_CR25","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3324\/haematol.2015.141218","volume":"101","author":"J Bond","year":"2016","unstructured":"Bond J, Marchand T, Touzart A, Cieslak A, Trinquand A, Sutton L, et al. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study. Haematologica. 2016;101:732\u201340.","journal-title":"Haematologica"},{"key":"613_CR26","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/leu.2015.177","volume":"30","author":"P Ruminy","year":"2016","unstructured":"Ruminy P, Marchand V, Buchbinder N, Larson T, Joly B, Penther D, et al. Multiplexed targeted sequencing of recurrent fusion genes in acute leukaemia. Leukemia. 2016;30:757\u201360.","journal-title":"Leukemia"},{"key":"613_CR27","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1038\/leu.2011.153","volume":"25","author":"AJ Deshpande","year":"2011","unstructured":"Deshpande AJ, Rouhi A, Lin Y, Stadler C, Greif PA, Arseni N, et al. The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice. Leukemia. 2011;25:1718\u201327.","journal-title":"Leukemia"},{"key":"613_CR28","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/leu.2008.278","volume":"23","author":"C Graux","year":"2009","unstructured":"Graux C, Stevens-Kroef M, Lafage M, Dastugue N, Harrison CJ, Mugneret F, et al. Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia. Leukemia. 2009;23:125\u201333.","journal-title":"Leukemia"},{"key":"613_CR29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/gcc.20743","volume":"49","author":"A Hagemeijer","year":"2010","unstructured":"Hagemeijer A, Graux C. ABL1 rearrangements in T-Cell acute lymphoblastic leukemia. Genes Chromosom Cancer. 2010;49:299\u2013308.","journal-title":"Genes Chromosom Cancer"},{"key":"613_CR30","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/gcc.22887","volume":"59","author":"MO Forgione","year":"2020","unstructured":"Forgione MO, McClure BJ, Yeung DT, Eadie LN, White DL. MLLT10 rearranged acute leukemia: incidence, prognosis, and possible therapeutic strategies. Genes, Chromosomes Cancer. 2020;59:709\u201321.","journal-title":"Genes, Chromosomes Cancer"},{"key":"613_CR31","doi-asserted-by":"crossref","unstructured":"t(10;11)(p13\u201314;q14\u201321): A New Recurrent Translocation in T-Cell Acute Lymphoblastic Leukemias. Groupe Fran\u00e7ais de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH). Genes Chromosom Cancer.1991;3:411\u20135.","DOI":"10.1002\/gcc.2870030602"},{"key":"613_CR32","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1182\/blood-2014-04-567636","volume":"124","author":"J Bond","year":"2014","unstructured":"Bond J, Bergon A, Durand A, Tigaud I, Thomas X, Asnafi V, et al. Cryptic XPO1-MLLT10 translocation is associated with HOXA locus deregulation in T-ALL. Blood. 2014;124:3023\u20135.","journal-title":"Blood"},{"key":"613_CR33","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/sj.leu.2404130","volume":"20","author":"SP Romana","year":"2006","unstructured":"Romana SP, Radford-Weiss I, Ben Abdelali R, Schluth C, Petit A, Dastugue N, et al. NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique. Leukemia. 2006;20:696\u2013706.","journal-title":"Leukemia"},{"key":"613_CR34","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.3324\/haematol.2013.086082","volume":"98","author":"R Ben Abdelali","year":"2013","unstructured":"Ben Abdelali R, Asnafi V, Petit A, Micol J-B, Callens C, Villarese P, et al. The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest. Haematologica. 2013;98:1711\u20137.","journal-title":"Haematologica"},{"key":"613_CR35","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1038\/leu.2013.149","volume":"27","author":"L Lo Nigro","year":"2013","unstructured":"Lo Nigro L, Mirabile E, Tumino M, Caserta C, Cazzaniga G, Rizzari C, et al. Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia. Leukemia. 2013;27:2419\u201321.","journal-title":"Leukemia"},{"key":"613_CR36","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1038\/sj.leu.2403891","volume":"19","author":"WA Dik","year":"2005","unstructured":"Dik WA, Brahim W, Braun C, Asnafi V, Dastugue N, Bernard OA, et al. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes. Leukemia. 2005;19:1948\u201357.","journal-title":"Leukemia"},{"key":"613_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cell.2005.02.020","volume":"121","author":"Y Okada","year":"2005","unstructured":"Okada Y, Feng Q, Lin Y, Jiang Q, Li Y, Coffield VM, et al. hDOT1L Links Histone Methylation to Leukemogenesis. Cell. 2005;121:167\u201378.","journal-title":"Cell"},{"key":"613_CR38","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/ncb1464","volume":"8","author":"Y Okada","year":"2006","unstructured":"Okada Y, Jiang Q, Lemieux M, Jeannotte L, Su L, Zhang Y. Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L. Nat Cell Biol. 2006;8:1017\u201324.","journal-title":"Nat Cell Biol"},{"key":"613_CR39","first-page":"1212","volume":"91","author":"M van Grotel","year":"2006","unstructured":"van Grotel M, Meijerink JP, Beverloo HB, Langerak AW, Buys-Gladdines JG, Schneider P, et al. The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. Haematologica. 2006;91:1212\u201321.","journal-title":"Haematologica"},{"key":"613_CR40","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/leu.2012.327","volume":"27","author":"L Chen","year":"2013","unstructured":"Chen L, Deshpande AJ, Banka D, Bernt KM, Dias S, Buske C, et al. Abrogation of MLL\u2013AF10 and CALM\u2013AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l. Leukemia. 2013;27:813\u201322.","journal-title":"Leukemia"},{"key":"613_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/gcc.2870090311","volume":"9","author":"NR McCabe","year":"1994","unstructured":"McCabe NR, Kipiniak M, Kobayashi H, Thirman M, Gill H, Rowley JD, et al. DNA rearrangements and altered transcripts of the MLL gene in a human T-all cell line karpas 45 with a t(X;II) (q13;q23) translocation. Genes Chromosom Cancer. 1994;9:221\u20134.","journal-title":"Genes Chromosom Cancer"},{"key":"613_CR42","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1182\/blood-2002-03-0717","volume":"99","author":"S Hayette","year":"2002","unstructured":"Hayette S, Tigaud I, Maguer-Satta V, Bartholin L, Thomas X, Charrin C, et al. Recurrent involvement of the MLL gene in adult T-lineage acute lymphoblastic leukemia. Blood. 2002;99:4647\u20139.","journal-title":"Blood"},{"key":"613_CR43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/(SICI)1098-2264(199604)15:4<206::AID-GCC2>3.0.CO;2-5","volume":"15","author":"S Tanabe","year":"1996","unstructured":"Tanabe S, Zeleznik-Le NJ, Kobayashi H, Vignon C, Espinosa R, LeBeau MM, et al. Analysis of the t(6;11)(q27;q23) in leukemia shows a consistent breakpoint in AF6 in three patients and in the ML-2 cell line. Genes Chromosom Cancer. 1996;15:206\u201316.","journal-title":"Genes Chromosom Cancer"},{"key":"613_CR44","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/gcc.22666","volume":"57","author":"JF Peterson","year":"2018","unstructured":"Peterson JF, Baughn LB, Pearce KE, Williamson CM, Benevides Demasi JC, Olson RM, et al. KMT2A (MLL) rearrangements observed in pediatric\/young adult T-lymphoblastic leukemia\/lymphoma: a 10-year review from a single cytogenetic laboratory. Genes Chromosom Cancer. 2018;57:541\u20136.","journal-title":"Genes Chromosom Cancer"},{"key":"613_CR45","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1182\/blood-2002-10-3221","volume":"102","author":"AA Ferrando","year":"2003","unstructured":"Ferrando AA, Armstrong SA, Neuberg DS, Sallan SE, Silverman LB, Korsmeyer SJ, et al. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. Blood. 2003;102:262\u20138. Epub 2003 Mar 13","journal-title":"Blood"},{"key":"613_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1200\/JCO.1999.17.1.191","volume":"17","author":"JE Rubnitz","year":"1999","unstructured":"Rubnitz JE, Camitta BM, Mahmoud H, Raimondi SC, Carroll AJ, Borowitz MJ, et al. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation. J Clin Oncol. 1999;17:191\u20136.","journal-title":"J Clin Oncol"},{"key":"613_CR47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00277-011-1289-x","volume":"91","author":"H Chae","year":"2012","unstructured":"Chae H, Lim J, Kim M, Park J, Kim Y, Han K, et al. Phenotypic and genetic characterization of adult T-cell acute lymphoblastic leukemia with del(9)(q34);SET-NUP214 rearrangement. Ann Hematol. 2012;91:193\u2013201.","journal-title":"Ann Hematol"},{"key":"613_CR48","first-page":"1","volume":"2","author":"H Quentmeier","year":"2009","unstructured":"Quentmeier H, Schneider B, R\u00f6hrs S, Romani J, Zaborski M, MacLeod RA, et al. SET-NUP214 fusion in acute myeloid leukemia- and T-cell acute lymphoblastic leukemia-derived cell lines. BioMed Central. 2009;2:1\u20135.","journal-title":"BioMed Central"},{"key":"613_CR49","doi-asserted-by":"publisher","first-page":"e46667","DOI":"10.7554\/eLife.46667","volume":"8","author":"M Oka","year":"2019","unstructured":"Oka M, Mura S, Otani M, Miyamoto Y, Nogami J, Maehara K, et al. Chromatin-bound CRM1 recruits SET-Nup214 and NPM1c onto HOX clusters causing aberrant HOX expression in leukemia cells. eLife. 2019;8:e46667.","journal-title":"eLife"},{"key":"613_CR50","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1128\/MCB.00158-16","volume":"36","author":"S Saito","year":"2016","unstructured":"Saito S, Cigdem S, Okuwaki M, Nagata K. Leukemia-Associated Nup214 Fusion Proteins Disturb the XPO1-Mediated Nuclear-Cytoplasmic Transport Pathway and Thereby the NF-\u03baB Signaling Pathway. Mol Cell Biol. 2016;36:1820\u201335.","journal-title":"Mol Cell Biol"},{"key":"613_CR51","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ccell.2018.07.007","volume":"34","author":"M Vanden Bempt","year":"2018","unstructured":"Vanden Bempt M, Demeyer S, Broux M, De Bie J, Bornschein S, Mentens N, et al. Cooperative Enhancer Activation by TLX1 and STAT5 Drives Development of NUP214-ABL1\/TLX1-Positive T Cell Acute Lymphoblastic Leukemia. Cancer Cell. 2018;34:271\u2013.e7.","journal-title":"Cancer Cell"},{"key":"613_CR52","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1182\/blood-2006-04-014514","volume":"108","author":"T Burmeister","year":"2006","unstructured":"Burmeister T, G\u00f6kbuget N, Reinhardt R, Rieder H, Hoelzer D, Schwartz S. NUP214-ABL1 in adult T-ALL: the GMALL study group experience. Blood. 2006;108:3556\u20139.","journal-title":"Blood"},{"key":"613_CR53","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1182\/blood-2004-12-4897","volume":"105","author":"K De Keersmaecker","year":"2005","unstructured":"De Keersmaecker K, Graux C, Odero MD, Mentens N, Somers R, Maertens J, et al. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32). Blood. 2005;105:4849\u201352.","journal-title":"Blood"},{"key":"613_CR54","first-page":"957","volume":"10","author":"S Schlieben","year":"1996","unstructured":"Schlieben S, Borkhardt A, Reinisch I, Ritterbach J, Janssen JW, Ratei R, et al. Incidence and clinical outcome of children with BCR\/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. Leukemia. 1996;10:957\u201363.","journal-title":"Leukemia"},{"key":"613_CR55","doi-asserted-by":"crossref","unstructured":"Keersmaecker KD, Porcu M, Cox L, Girardi T, Vandepoel R, Beeck JO de et al. NUP214-ABL1-mediated cell proliferation in T-cell acute lymphoblastic leukemia is dependent on the LCK kinase and various interacting proteins. 2014;99:85\u201393.","DOI":"10.3324\/haematol.2013.088674"},{"key":"613_CR56","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/ng1425","volume":"36","author":"C Graux","year":"2004","unstructured":"Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R, et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet. 2004;36:1084\u20139.","journal-title":"Nat Genet"},{"key":"613_CR57","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/leu.2008.80","volume":"22","author":"A Quint\u00e1s-Cardama","year":"2008","unstructured":"Quint\u00e1s-Cardama A, Tong W, Manshouri T, Vega F, Lennon PA, Cools J, et al. Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies. Leukemia. 2008;22:1117\u201324.","journal-title":"Leukemia"},{"key":"613_CR58","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.3324\/haematol.13291","volume":"93","author":"P Ballerini","year":"2008","unstructured":"Ballerini P, Landman-Parker J, Cayuela JM, Asnafi V, Labopin M, Gandemer V, et al. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3\/HOX11L2 gene expression on outcome. Haematologica. 2008;93:1658\u201365.","journal-title":"Haematologica"},{"key":"613_CR59","doi-asserted-by":"crossref","unstructured":"Wasylyk B, Hahn SL, Giovane A. The Ets family of transcription factors. In: Christen P, Hofmann E, editors. EJB Reviews 1993. Berlin, Heidelberg:Springer;1994. p. 7\u201318.","DOI":"10.1007\/978-3-642-78757-7_2"},{"key":"613_CR60","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1172\/JCI129126","volume":"130","author":"S Klossowski","year":"2020","unstructured":"Klossowski S, Miao H, Kempinska K, Wu T, Purohit T, Kim E, et al. Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia. J Clin Investig. 2020;130:981\u201397.","journal-title":"J Clin Investig"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-022-00613-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-022-00613-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-022-00613-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T08:30:52Z","timestamp":1700123452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-022-00613-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,26]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["613"],"URL":"https:\/\/doi.org\/10.1038\/s41408-022-00613-9","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,26]]},"assertion":[{"value":"2 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}